2m 2m 2m 2m 2m 2m 2m
GOSSAMER BIO (GOSS)
NASDAQ
$0.19-$0.01 (-7.09%)
Price as of Jun 03, 2026 7:08 PM EDT- $54.2MMarket Cap
- -83.59%1-Year Change
- BiotechnologyIndustry
GOSSAMER BIO (GOSS)
$0.19-$0.01 (-7.09%)
GOSS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.20 | ||
Change | +$0.002 (+1.06%) | ||
Open | $0.20 | ||
High | $0.20 | ||
Low | $0.20 | ||
Previous Close | $0.20 | ||
Volume | 11,592,120 | ||
30-Day Average Volume | 12,962,782 | ||
1-Week Change | -9.00% | ||
1-Month Change | -45.86% | ||
1-Year Change | -83.59% | ||
3-Year Change | -84.72% | ||
5-Year Change | -97.68% | ||
Fundamentals | |||
Shares Outstanding | 234.7M | ||
Total Assets | $128.9M | ||
Market Cap | $54.2M | ||
Enterprise Value | $211.9M | ||
Period: QTR TTM FY | |||
Revenue | $17.0M | ||
Net Income | -$46.7M | ||
Free Cash Flow | -$38.7M | ||
EBIT | -$43.9M | ||
EBITDA | -$43.9M | ||
Net Working Capital | $68.0M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 12 | ||
P/B | -0 | ||
P/E | -1 | ||
PEG | -1 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue